Trials / Completed
CompletedNCT01490814
FIRE AND ICE: Comparative Study of Two Ablation Procedures in Patients With Atrial Fibrillation
A Controlled, Prospective, Non-Inferiority, Parallel-Group, Randomised, Interventional, Open, Blinded Outcome Assessment (PROBE-Design), Multi-centre Trial, Comparing Efficacy and Safety of Isolation of the PVs With a Cryoballoon Catheter vs a Radiofrequency Ablation With a ThermoCool Catheter in Patients With PAF
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 769 (actual)
- Sponsor
- Medtronic Cardiac Ablation Solutions · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Comparing efficacy and safety of isolation of the pulmonary veins (PV) using a Cryoballoon catheter versus a radiofrequency ablation with a ThermoCool catheter in patients with paroxysmal atrial fibrillation.
Detailed description
The purpose of this randomized clinical trial is to compare the efficacy and safety of isolating the PVs with either the cryoballoon or a RF ablation technique with a ThermoCool catheter, a system which can be regarded as standard for ablation. In total 762 patients with paroxysmal atrial fibrillation has been randomized for either radiofrequency (RF) or cryoballoon. With both techniques, PV isolation will be performed. Primary end point of the trial is the time to first recurrence of atrial arrhythmias or prescription of anti-arrhythmic drugs after a blanking period of three months. Treatment success will be evaluated by using weekly electrocardiography (ECG) monitoring (transtelephonic transmission/Tele-ECG) and using Holter electrocardiograms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Electrical isolation of the pulmonary veins | Device: ArcticFront® Cardiac CryoAblation Catheter System with the FlexCath Steerable Sheath or ArcticFront® Advance Cardiac CryoAblation Catheter System with the FlexCath Steerable Sheath or any future development generations of this product line, provided they are CE marked and the centre has the experience of at least 10 procedures before including a patient into the study. |
| PROCEDURE | Electrical isolation of pulmonary veins | Device:NaviStar® ThermoCool® Irrigated Tip Ablation Catheter in combination with 3D mapping system CARTO or any future development generations of this product line, provided they are CE marked and the centre has the experience of at least 10 procedures before including a patient into the study. |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2011-12-13
- Last updated
- 2026-04-13
- Results posted
- 2018-11-02
Locations
19 sites across 8 countries: Czechia, France, Germany, Hungary, Italy, Netherlands, Spain, Switzerland
Source: ClinicalTrials.gov record NCT01490814. Inclusion in this directory is not an endorsement.